Physician profile
Amy M Beicker
NPI 1871732073
$754.17
in general payments reported to CMS, 2019-2025
9 companies · $362 in 2025
The $362 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $106 · 2022: $43.58 · 2023: $173 · 2024: $69.03 · 2025: $362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $429 · Consulting Fee: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $429.42 |
| Consulting Fee | $175.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $252.14 | 2021-2025 | Prolia, Evenity |
| Arthrex, INC. | $153.84 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $116.82 | 2024-2025 | |
| Radius Health, INC. | $110.58 | 2021-2025 | Tymlos |
| Pacira Pharmaceuticals Incorporated | $38.15 | 2025 | Exparel, Zilretta |
| Solventum Corporation | $28.41 | 2025 | Promogran Prisma, V.A.C. Granufoam, Activ.A.C. |
| Medacta USA, INC. | $19.34 | 2023 | Gmk Revision |
| Pacira Therapeutics, INC. | $17.54 | 2021 | |
| Convatec INC. | $17.35 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Beicker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.